Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Alkim Alkali Kimya AS's Days Sales Outstanding for the
three
months ended in Dec. 2025 was 55.20.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Alkim Alkali Kimya AS's liquidation value for the
three
months ended in Dec. 2025 was ₺-268 Mil.
Alkim Alkali Kimya AS (IST:ALKIM) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Alkim Alkali Kimya AS's Days Sales Outstanding for the quarter that ended in Dec. 2025 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alkim Alkali Kimya AS Change In Receivables Related Terms
Alkim Alkali Kimya AS Change In Receivables Historical Data
* Premium members only.
The historical data trend for Alkim Alkali Kimya AS's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alkim Alkali Kimya AS Change In Receivables Calculation
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺121 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Change In Receivables of ₺121 Mil mean?
Alkim Alkali Kimya AS (IST:ALKIM) has a Change In Receivables of ₺121 Mil as of Dec. 2025. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Alkim Alkali Kimya AS and its competitors.
Is Alkim Alkali Kimya AS's Change In Receivables too high?
Alkim Alkali Kimya AS's current Change In Receivables is ₺121 Mil. Overall, Alkim Alkali Kimya AS has a GF Score™ of 61/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Alkim Alkali Kimya AS's Change In Receivables compare to SLVM?
Alkim Alkali Kimya AS's Change In Receivables of ₺121 Mil can be compared against companies in the Forest Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Forest Products company?
A good Change In Receivables depends on the Forest Products industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Alkim Alkali Kimya AS and its competitors. Alkim Alkali Kimya AS's current Change In Receivables is ₺121 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alkim Alkali Kimya AS stock overvalued right now?
Based on GuruFocus' analysis, Alkim Alkali Kimya AS (IST:ALKIM) is currently considered Modestly Overvalued. The stock's GF Value™ is ₺14.59, compared to a current price of ₺17.81 — trading 22.1% above its estimated fair value. The current Change In Receivables is ₺121 Mil. Alkim Alkali Kimya AS's overall GF Score™ is 61/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Alkim Alkali Kimya AS (IST:ALKIM), the current Change In Receivables is ₺121 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alkim Alkali Kimya AS (IST:ALKIM) Overvalued in 2026?
Based on GuruFocus' analysis, Alkim Alkali Kimya AS stock appears to be overvalued.
The current stock price of ₺17.81 is trading 22.1% above its estimated GF Value™ of ₺14.59.
GuruFocus considers Alkim Alkali Kimya AS to be Modestly Overvalued.
Key valuation signals for IST:ALKIM:
Change In Receivables: ₺121 Mil
GF Value™: ₺14.59 vs. price of ₺17.81 (22.1% above fair value)
No single metric tells the full story. See the IST:ALKIM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alkim Alkali Kimya AS is a Turkey-based company engaged in the paper and chemical business activity. The business segments of the group are Chemical products which involves the production and sales of Sodium Sulphate and derivatives; Paper segment covering production and sales of paper products and Other operations segment. It derives key revenue from the Paper segment.
61GF Score
Get the complete analysis for IST:ALKIM
Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:ALKIM has been successfully added to your 
